Jane Harness

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality

Donald J. Nichols, Gary J. Muirhead, Jane Harness · British Journal of Clinical Pharmacology · 2002 · 352 citations · Full text

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

Kim Papp, Alan Menter, Bruce Strober et al. · British Journal of Dermatology · 2012 · 328 citations

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

Bruce Strober, M. Buonanno, James D. Clark et al. · British Journal of Dermatology · 2013 · 94 citations

Tofacitinib (<scp>CP</scp>‐690,550), an oral Janus kinase inhibitor, improves patient‐reported outcomes in a phase 2b, randomized, double‐blind, placebo‐controlled study in patients with moderate‐to‐severe psoriasis

Carla Mamolo, Jane Harness, Huaming Tan et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 76 citations

The effects of sildenafil on human sperm function in healthy volunteers

Ken Purvis, Gary J. Muirhead, Jane Harness · British Journal of Clinical Pharmacology · 2002 · 59 citations · Full text